High materiality8/10
Agilon Health price target raised to $146 from $141 at Wells Fargo
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo raises AGL's price target to $146; current price approximately $96.78. The target upgrade implies meaningful upside potential and a positive reassessment by a top broker. PriceChangeSinceSignal ≈ +2.59% since the signal.
- Analyst target upgrade: AGL to $146
- Posted price: $96.78
- Firm: Wells Fargo; Analyst: Stephen Baxter
Key facts
- 01
Target: $146
- 02
Posted price: $96.78
- 03
Analyst firm: Wells Fargo
- 04
Analyst: Stephen Baxter
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.